A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent Subjects
Stopped Study withdrawn prior to enrollment due to strategic portfolio decisions following divestiture of the investigational product.
Conditions
- Opioid Withdrawal (Disorder)
- Opioid Use Disorder
Interventions
- DRUG: LUCEMYRA (lofexidine) tablets
Sponsor
USWM, LLC (dba US WorldMeds)
Collaborators